- Country: Ukraine
- Summary: Tranexamic Acid Solution for Injection, 100 Mg/Ml in 5 Ml (Tranexamic Acid); Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 10 Ml each (Magnesium Sulfate); Lidocaine, Solution for Injection, 20 Mg/Ml, Po...
- UAT Ref No: 131910514
- Deadline: 14 Dec 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: UAH 100000
- Notice Type: Tender
- Document Ref. No.: UA-2025-12-09-004458-a
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tranexamic acid solution for injection, 100 mg/ml in 5 ml (Tranexamic acid); Magnesium sulfate, solution for injection, 250 mg/ml, 10 ml each (Magnesium sulfate); Lidocaine, solution for injection, 20 mg/ml, 2 ml each (Lidocaine); Glucose solution for infusions 5% in 200 ml (glass) (Glucose); Captopril, tablets, 25 mg each (Captopril); Amiodarone, solution for injection, 50 mg/ml, 3 ml each (Amiodarone); Tranexamic acid solution for injection, 50 mg/ml in 5 ml (Tranexamic acid); Bupivacaine, solution for injection, 5 mg/ml, 4 ml each (Bupivacaine); Furosemide, solution for injection, 10 mg/ml, 2 ml each (Furosemide); Enoxaparin sodium, solution for injection, 10,000 anti-Xa IU/ml, 0.4 ml each (Enoxaparin); Diclofenac solution for injections 25 mg/ml (Diclofenac); Amoxicillin and clavulanic acid, powder for injections/infusions 1.2 g (Amoxicillin and beta-lactamase inhibitor); Dexamethasone, solution for injection 4mg/ml (Dexamethasone); Platyphylline solution for injection, 2 mg/ml, 1 ml each (Platyphylline); Human insulin (short-acting), solution for injection, 100 Units/ml, bottle, 10 ml each (Insulin (human)); Ringer's solution for infusions 250 ml (Electrolytes); Norepinephrine, concentrate for solution for infusions, 2 mg/ml in 8 ml (Norepinephrine); Meropenem, powder for injections/infusions, 1 g each (Meropenem); Caffeine Citrate, solution for infusions and oral use, 20 mg/ml, 1 ml each (Caffeine) Purchase type: goods Classifier and its corresponding code: DK 021:2015: 33600000-6 — Pharmaceutical products Glucose solutions: Classification according to INN: Glucose, Dose of active substance: 50 mg/ml, Release form: Solution for infusion, Volume: 200, Packaging type: Vial, Bottle, Classification according to ATX: B05CX01; Classification according to INN: Electrolytes, Classification according to ATX: B05BB01, Release form: Solution for infusions, Type of packaging: Vial, Container, Bottle, Package, Volume: 250 ml, Potassium chloride: 0.3 mg/ml, Calcium chloride...
- Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTranexamic Acid Solution for Injection, 100 Mg/Ml in 5 Ml (Tranexamic Acid); Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 10 Ml each (Magnesium Sulfate); Lidocaine, Solution for Injection, 20 Mg/Ml, Po... - Ukraine Tender
The MUNICIPAL NON-COMMERCIAL ENTERPRISE "HOLOVANIVSKY HOSPITAL" OF HOLOVANIVSKY VILLAGE COUNCIL OF HOLOVANIVSKY DISTRICT OF KIROVOGRAD OBLAST, a Government sector organization in Ukraine, has announced a new tender for Tranexamic Acid Solution for Injection, 100 Mg/Ml in 5 Ml (Tranexamic Acid); Magnesium Sulfate, Solution for Injection, 250 Mg/Ml, 10 Ml each (Magnesium Sulfate); Lidocaine, Solution for Injection, 20 Mg/Ml, Po.... This tender is published on UkraineTenders under UAT Ref No: 131910514 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-12-14.
The estimated tender value is UAH 100000, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
